AbbVie drops Shire bid
This article was originally published in Scrip
Executive Summary
Just hours after Shire said it was waiving the three-day notice period for AbbVie's board to meet to consider its offer for Shire "in order to allow the period of uncertainty for its shareholders, employees and other stakeholders to be reduced," AbbVie's board, with major egg on its face, has announced that it is recommending shareholders vote against the Shire transaction.